Search Results 1321-1330 of 15902 for Fosaprepitant

  1. Peripheral nerve tumors - Doctors and departments - Mayo Clinic

    Learn about these growths that form in or near nerves connecting to the spinal cord. Surgery is the most common treatment.

  2. Peripheral nerve tumors - Doctors and departments - Mayo Clinic

    Learn about these growths that form in or near nerves connecting to the spinal cord. Surgery is the most common treatment.

  3. Peripheral nerve tumors - Doctors and departments - Mayo Clinic

    Learn about these growths that form in or near nerves connecting to the spinal cord. Surgery is the most common treatment.

  4. Peripheral nerve tumors - Doctors and departments - Mayo Clinic

    Learn about these growths that form in or near nerves connecting to the spinal cord. Surgery is the most common treatment.

  5. Peripheral nerve tumors - Doctors and departments - Mayo Clinic

    Learn about these growths that form in or near nerves connecting to the spinal cord. Surgery is the most common treatment.

  6. Medical Research & Education - Mayo Clinic News Network

    Marla Broadfoot, Ph.D. March 26, 2026. Immunotherapy boosts chemotherapy in combating stage 3 colon cancer featured image. Cancer.

  7. Peripheral nerve tumors - Doctors and departments - Mayo Clinic

    Learn about these growths that form in or near nerves connecting to the spinal cord. Surgery is the most common treatment.

  8. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

    This rare type of cancer can begin in the muscles, fat, blood vessels, nerves, tendons and the lining of joints. Treatment usually includes surgery.

  9. Gastroenterology and Hepatology - Clinical trials

    Other enteropathies will also be included: collagenous sprue, idiopathic sprue, lymphocytic enterocolitis, idiopathic enteropathies, collagenous gastritis, ...

  10. A Study to Evaluate Abemaciclib to Treat Advanced Bone and Soft Tissue Sarcoma Identified as Having CDK Pathway Alteration - Mayo Clinic

    The purpose of this study is to evaluate the 12-week progression free survival (PFS) rate in treated subjects, based on historical sarcoma trial outcomes (PFS ...